The aim of this work was to perform a comparative analysis of the prevalence and clinical and laboratory features of the course of COVID-19 infection in patients with end-stage chronic kidney disease receiving kidney replacement therapy (KRT). Methods. A retrospective analysis of 73 medical records of patients undergoing KRT and infected COVID-19 between January 1, 2021 and December 31, 2021. The patients were divided into two groups. The first group consisted of 54 hemodialysis (HD) patients, and the second group included 19 peritoneal dialysis (PD) patients. Routine clinical and laboratory characteristics, morbidity, and mortality of COVID-19 depending on KRT modality were analysed. Results. The overall prevalence of COVID-19 was 37.63%. Mortality in this cohort of patients was 19.07%, and mortality associated with COVID-19 was 6.19%. Despite the predominance of COVID-19-associated morbidity in HD patients (46.55% vs. 24.36%, p = 0.05), mortality was not statistically significantly different between the studied groups (26.32% in PD patients vs. 12.96% in HD patients, p = 0.17). HD patients had more severe lung injury as measured by SpO2 (p=0.18) and CT (p=0.003), while PD patients had lower hemoglobin (p=0.001), platelet (p=0.001), total protein (p<0.001), and albumin (p<0.001) levels. A direct correlation was found between the percentage of lung injury according to the CT data and the leukocyte count in both the HD (r = 0.24) and PD (r = 0.56) groups. In addition, an inverse correlation between leukocyte and SpO2 values and between the percentage of lung injury according to the CT data and SpO2 indicators was found in the HD (r = -0.51 and r = -0.66) and PD (r = -0.47 and r = -0.63) groups, respectively. Conclusions. The results of our study are in complete agreement with published data and show the same COVID-19-associated mortality in HD and PD patients, with a statistically significantly higher prevalence of COVID-19 in HD patients. The course of COVID-19 in HD patients is characterized by more severe lung injury compared to PD patients, while PD patients had more pronounced anemia and significantly lower platelet, total protein, and blood albumin concentrations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.